WM
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Serapha Bio
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
www.seraphabio.comRevenue
<$5 MillionIndustry
About Serapha Bio
Serapha Bio is a clinical-stage biotechnology company developing gene-editing therapies for genetic diseases. Its lead program, SERP-01, is an in vivo base-editing treatment designed to correct the underlying mutation responsible for Alpha-1 Antitrypsin Deficiency (AATD). Founded by leading life sciences investors, the company focuses on advancing precision genetic medicines that have the potential to provide durable, disease-modifying outcomes for patients with serious inherited disorders.Explore more
SIC Code 87,873NAICS Code 54,541Show moreSerapha Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Serapha Bio
Sign Up For FreeTo access detailed company insights
Serapha Bio is a clinical-stage biotechnology company developing gene-editing therapies for genetic diseases. Its lead program, SERP-01, is an in vivo base-editing treatment designed to correct the underlying mutation responsible for Alpha-1 Antitrypsin Deficiency (AATD). Founded by leading life sciences investors, the company focuses on advancing... Read More
